The tweet was deleted by the author.
But we saved everything 🙂.
Guy LeBas points out that complexities in Consumer Price Index (CPI) data collection can lead to certain costs being overlooked. He explains that while cash drug costs have decreased, the overall expense has not dropped as much because some costs were moved to areas not tracked by the CPI.
View post on X Loading...
LeBas has recently projected that July core PCE would rise 0.27 percent month over month, based on his review of CPI and PPI figures in a previous analysis. He also noted that markets were pricing a 40 percent chance of a U.S. rate hike in September, citing uncertain policy guidance in recent comments. These observations follow his ongoing focus on the nuances within key economic indicators.